About
ImmuneSpec provides specialized immunopeptidomics laboratory services including MHC-associated peptide proteomics (MAPPs) to support immunogenicity risk assessment, target discovery, and construct validation for biotherapeutic development, vaccine design, and immuno-oncology research.
Explore ImmuneSpec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.